EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

T‐cell immune profile in blood of systemic mastocytosis: Association with disease features

Alba Pérez-Pons iD, Cristina Teodosio, María Jara-Acevedo, Ana Henriques, Paula Navarro-Navarro iD, Andrés C García-Montero, Iván Álvarez-Twose, Quentin Lecrevisse, Rafael Fluxa, Laura Sánchez-Muñoz, Carolina Caldas, Julio Pozo and 7 more

Allergy · 2024

DOI: 10.1111/all.16043 ↗

At a glance

Journal article in Allergy, 2024. Written by Alba Pérez-Pons and 18 co-authors. Institution: Department of Medicine and Cytometry Service (NUCLEUS), Cancer Research Center (IBMCC, USAL-CSIC), Universidad de Salamanca, Salamanca, Spain. Major MEDLINE topics: Mastocytosis, Systemic. Cited 5 times so far (Crossref); 64 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: HORIZON EUROPE Marie Sklodowska-Curie Actions, Junta de Castilla y León, European Regional Development Fund.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Systemic mastocytosis (SM) is a heterogeneous disease characterized by an expansion of KIT ‐mutated mast cells (MC). KIT ‐mutated MC display activated features and release MC mediators that might act on the tumour microenvironment and other immune cells. Here, we investigated the distribution of lymphocyte subsets in blood of patients with distinct subtypes of SM and determined its association with other disease features.

Methods

We studied the distribution of TCD4 + and TCD4 − cytotoxic cells and their subsets, as well as total NK‐ and B cells, in blood of 115 SM patients—38 bone marrow mastocytosis (BMM), 67 indolent SM (ISM), 10 aggressive SM (ASM)‐ and 83 age‐matched healthy donors (HD), using spectral flow cytometry and the EuroFlow Immunomonitoring panel, and correlated it with multilineage KIT D816V , the alpha‐tryptasemia genotype (HαT) and the clinical manifestations of the disease.

Results

SM patients showed decreased counts (vs. HD) of TCD4 − cytotoxic cells, NK cells and several functional subsets of TCD4 + cells (total Th1, Th2‐effector memory, Th22‐terminal effector and Th1‐like Tregs), together with increased T‐follicular‐helper and Th1/Th17‐like Treg counts, associated with different immune profiles per diagnostic subtype of SM, in multilineal versus MC‐restricted KIT D816V and in cases with a HαT + versus HαT − genotype. Unique immune profiles were found among BMM and ISM patients with MC‐restricted KIT D816V who displayed HαT, anaphylaxis, hymenoptera venom allergy, bone disease, pruritus, flushing and GI symptoms.

Conclusion

Our results reveal altered T‐ and NK‐cell immune profiles in blood of SM, which vary per disease subtype, the pattern of involvement of haematopoiesis by KIT D816V , the HαT genotype and specific clinical manifestations of the disease.

Subjects

MeSH terms (MEDLINE)

Mastocytosis, SystemicHumansMaleMiddle AgedFemaleAdultAgedT-Lymphocyte SubsetsImmunophenotypingProto-Oncogene Proteins c-kitYoung AdultMutationAged, 80 and overMast CellsKiller Cells, Natural

Author keywords

cytotoxic T cellshelper T cellslymphocytesmast cellssystemic mastocytosis

Substances

Proto-Oncogene Proteins c-kit

Authors and institutions

  • Department of Medicine and Cytometry Service (NUCLEUS), Cancer Research Center (IBMCC, USAL-CSIC), Universidad de Salamanca, Salamanca, Spain.
  • Biomedical Research Networking Center Consortium (CIBERONC; CB16/12/00400), Madrid, Spain.
  • Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.
  • Spanish Network on Mastocytosis (REMA), Toledo, Salamanca, Spain.
  • Sequencing Service (NUCLEUS), Universidad de Salamanca, Salamanca, Spain.
  • Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast), Virgen del Valle Hospital, CIBERONC, Toledo, Madrid, Spain.

ORCID profiles: Alba Pérez-Pons, Paula Navarro-Navarro, Oscar González-López, Andrea Mayado, Alberto Orfao

Funding

  • HORIZON EUROPE Marie Sklodowska-Curie Actions
  • Junta de Castilla y León
  • European Regional Development Fund
  • Centro de Investigación Biomédica en Red de Cáncer
  • Instituto de Salud Carlos III

Cite

APA

Pérez-Pons, A., Teodosio, C., Jara-Acevedo, M., Henriques, A., Navarro-Navarro, P., García-Montero, A. C., Álvarez-Twose, I., Lecrevisse, Q., Fluxa, R., Sánchez-Muñoz, L., Caldas, C., Pozo, J., Martín, S., Sanfeliciano, T. C., Pedreira, C. E., Botafogo, V., González-López, O., Mayado, A., & Orfao, A. (2024). T‐cell immune profile in blood of systemic mastocytosis: Association with disease features. Allergy. https://doi.org/10.1111/all.16043

Vancouver

Pérez-Pons A, Teodosio C, Jara-Acevedo M, Henriques A, Navarro-Navarro P, García-Montero AC, et al. T‐cell immune profile in blood of systemic mastocytosis: Association with disease features. Allergy. 2024. doi:10.1111/all.16043

BibTeX
@article{PrezPons2024,
  author = {Pérez-Pons, Alba and Teodosio, Cristina and Jara-Acevedo, María and Henriques, Ana and Navarro-Navarro, Paula and García-Montero, Andrés C and Álvarez-Twose, Iván and Lecrevisse, Quentin and Fluxa, Rafael and Sánchez-Muñoz, Laura and Caldas, Carolina and Pozo, Julio and Martín, Silvia and Sanfeliciano, Teresa Contreras and Pedreira, Carlos E and Botafogo, Vitor and González-López, Oscar and Mayado, Andrea and Orfao, Alberto},
  title = {T‐cell immune profile in blood of systemic mastocytosis: Association with disease features},
  journal = {Allergy},
  year = {2024},
  doi = {10.1111/all.16043}
}
Start for free →